Abstract
161P - Efficacy and safety of modified ECF regimen as first-line chemotherapy in metastatic gastric adenocarcinoma: A phase II study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/annonc/mdy432.013
Publication Date: Nov 1, 2018 | |
License type: publisher-specific-oa |
161P - Efficacy and safety of modified ECF regimen as first-line chemotherapy in metastatic gastric adenocarcinoma: A phase II study
Join us for a 30 min session where you can share your feedback and ask us any queries you have